Cubist Pharmaceuticals, Inc. (CBST)

[Telephonics]

Cubist Pharma Swings to 2Q Profit
AP via Yahoo! Finance Wed, 18 Jul 2007 2:24 PM PDT
Biotechnology company Cubist Pharmaceuticals Inc. said Wednesday it swung to a second-quarter profit on higher sales of its skin infection treatment Cubicin.

Cubist Pharmaceuticals Reports Second Quarter 2007 Results: Total Revenues $69.8 Million; Net Product Revenues $69.5 ...
Business Wire via Yahoo! Finance Wed, 18 Jul 2007 1:01 PM PDT
LEXINGTON, Mass.----Cubist Pharmaceuticals, Inc. today reported results for the second quarter ended June 30, 2007. Net sales of CUBICIN® increased 52% from the prior year, from $45.7 million in the second quarter of 2006 to $69.5 million in the second quarter of 2007. U.S. net product revenue was $68.3 million.